Immune Response and Prognosis: CXCL9, CXCL10, and CXCL13 are linked to favorable prognosis due to their role in enhancing the immune response at the tumor site, suggesting their potential as biomarkers for immune contexture in cancer. This evidence concerns the gene CXCL13 and cancer.